Digital Health Startups

Peer AI builds AI-powered tools for drug development and clinical research, with a focus on medical writing and regulatory work. It serves life sciences and pharma organizations, combining generative AI with expertise in data protection and privacy.

1 investor

Peerbridge Health develops solutions focused on cardiac care and clinical insight.

1 investor

Pentec Health is a national provider of clinical nutrition and specialty care services, integrating pharmacy services with clinical expertise for patients with complex conditions including dialysis, wound care, metabolic disorders, and oncology needs. The company delivers home-based and clinical infusion therapies, compounded medications, and nutritional support to over 12,500 patients through a team of 350+ clinicians.

1 investor

PEP Health uses AI to analyze millions of unsolicited patient comments and turn them into benchmarkable, predictive insights on care quality, patient experience, and reputation. It serves healthcare leaders, physicians, and frontline staff—such as hospitals and health systems—to improve clinical and financial outcomes and Star Ratings.

1 investor

PeraHealth offers the Rothman Index, an FDA-cleared AI predictive analytics system that extracts and analyzes clinical measurements from the EMR to detect patient deterioration early and produce an aggregated score of a patient's physiological condition. It is used by clinicians in hospitals—including medical/surgical, intermediate, and intensive care units, with a pediatric variant—to guide care escalation, safe downgrades, and discharge readiness decisions.

1 investor

Perceptic builds an AI platform that unifies evidence, data, and decision workflows across the drug development lifecycle, connecting asset scouting, scientific evaluation, and clinical data on a shared intelligence layer. It targets pharmaceutical and drug development organizations, providing traceable, data-backed decision-making with AI-assisted reasoning.

1 investor

Perception Medicine develops AI-driven precision oncology solutions for cancer patients. The company's team combines expertise in artificial intelligence, clinical medicine, and product design, with roots in Stanford and MIT research.

1 investor

Perception Neuroscience is a clinical-stage biotech developing R-ketamine (PCN-101), a single-isomer glutamatergic modulator being studied as a rapid-acting antidepressant for patients with treatment-resistant depression. The company licenses intellectual property originally discovered at Chiba University and is running a Phase 2a proof-of-concept clinical trial.

1 investor

Percy provides data-driven sleep diagnostics and behavioral sleep therapy tools for healthcare providers treating sleep disorders, particularly for neurodivergent populations and people with chronic medical conditions.

1 investor

Peregrine Health partners with Federally Qualified Health Centers (FQHCs) to design, manage, and operate behavioral health service lines by placing licensed clinicians, handling program operations, and providing a technology platform for scheduling and outcome tracking. It serves community health centers addressing mental health and substance use care, offering programs such as Behavioral Health Integration and Medication-Assisted Treatment.

1 investor

Peregrine Health develops behavioral health care solutions for federally qualified health centers (FQHCs) to expand access to mental health services for underserved communities. The company tailors implementation and support to help FQHCs reach more patients in need.

1 investor

PerfectServe provides communication and coordination software for healthcare organizations, including secure messaging, patient engagement, case scheduling, and emergency notification capabilities for hospital operations and call centers.

1 investor

Performant provides payment integrity services for commercial healthcare and government payers, identifying, preventing, and recovering waste, improper payments, and defaulted assets across Medicare, Medicaid, and commercial health plans. The company offers analytics and workflow technology plus professional services to help payers recover and prevent payment discrepancies.

1 investor

Performation provides business intelligence, data analytics, and monitoring software and consulting for the healthcare sector, covering areas such as care registration, capacity planning, and real-world monitoring. The company employs consultants, software engineers, and data specialists to support healthcare organizations.

1 investor

PeriGen develops software technology that identifies potential complications during childbirth to help clinicians around the world prevent avoidable harm during labor and delivery. The company serves healthcare providers and perinatal care teams globally.

1 investor

Perigon Health provides a digital health platform that integrates medication dispensing devices, physiological monitoring, and reimbursement systems to track patient adherence and improve medication outcomes. The platform connects health APIs and serves healthcare providers and pharmacies seeking enhanced patient insight and reimbursement efficiency.

1 investor

Perimeter Healthcare develops behavioral health care services and evidence-based protocols to treat patients with mental illness. The company focuses on building an integrated health care system for mental health treatment.

1 investor

Perimeter Medical Imaging AI develops ultra-high resolution imaging tools and AI software to help surgeons assess tumor margins during cancer surgery in real-time. The Toronto-based company aims to reduce the need for repeat surgeries by enabling surgeons to detect remaining cancer cells using proprietary Optical Coherence Tomography technology.

1 investor

Perinatal Access provides board-certified maternal-fetal medicine (MFM) specialist care to underserved and rural communities in the U.S., aiming to reduce maternal mortality by expanding access to high-risk pregnancy expertise. It targets areas where MFM specialists are scarce, connecting rural mothers with specialist care.

1 investor

Periotherapia develops antibody-based therapeutics targeting pathological periostin in the stromal environment to treat refractory diseases including cancer, diabetic retinopathy, and heart disease. The company, spun out from Osaka University, is conducting clinical trials for HER2-negative triple-negative breast cancer with support from Japan's AMED program.

1 investor

Perlman Clinic provides primary care, urgent care, and specialty medical services including mental health, dermatology, and weight management across San Diego and Orange County.

1 investor

Perry offers a holistic perimenopause support platform combining a peer community, evidence-based nutrition and emotional guidance, and access to women's health specialists. It serves women aged 40+ navigating perimenopause, and also runs a podcast, published journal, and a network for perimenopause-competent health professionals.

1 investor

Perseo Pharma is a biotech spin-off from the University of Applied Sciences in Basel, Switzerland, developing enzyme immobilization and bioconjugation technologies for therapeutic applications. The company focuses on creating novel platforms for drug delivery and enzyme-based therapies targeting inborn errors of metabolism and other rare diseases.

1 investor

Persephone develops a synbiotic supplement for infants that combines probiotics (keystone Bifidobacterium strains) with prebiotics found in human breast milk to replenish gut bacteria linked to digestion, immunity, and development. The product was developed by microbiome scientists and pediatricians and validated in a clinical study.

1 investor